- Home
- RCUS vs UAN Comparison
RCUS vs UAN Comparison
Compare RCUS & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- UAN
- Stock Information
- Founded
- RCUS 2015
- UAN 2007
- Country
- RCUS United States
- UAN United States
- Employees
- RCUS N/A
- UAN N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- RCUS Health Care
- UAN Industrials
- Exchange
- RCUS Nasdaq
- UAN Nasdaq
- Market Cap
- RCUS 727.1M
- UAN 773.6M
- IPO Year
- RCUS 2018
- UAN 2011
- Fundamental
- Price
- RCUS $7.88
- UAN $74.44
- Analyst Decision
- RCUS Strong Buy
- UAN
- Analyst Count
- RCUS 10
- UAN 0
- Target Price
- RCUS $29.50
- UAN N/A
- AVG Volume (30 Days)
- RCUS 1.2M
- UAN 35.3K
- Earning Date
- RCUS 05-07-2025
- UAN 04-28-2025
- Dividend Yield
- RCUS N/A
- UAN 9.08%
- EPS Growth
- RCUS N/A
- UAN N/A
- EPS
- RCUS N/A
- UAN 5.76
- Revenue
- RCUS $258,000,000.00
- UAN $525,323,999.00
- Revenue This Year
- RCUS N/A
- UAN N/A
- Revenue Next Year
- RCUS $25.77
- UAN N/A
- P/E Ratio
- RCUS N/A
- UAN $12.92
- Revenue Growth
- RCUS 120.51
- UAN N/A
- 52 Week Low
- RCUS $6.50
- UAN $62.94
- 52 Week High
- RCUS $18.98
- UAN $88.94
- Technical
- Relative Strength Index (RSI)
- RCUS 44.26
- UAN 52.91
- Support Level
- RCUS $6.75
- UAN $66.00
- Resistance Level
- RCUS $8.36
- UAN $74.95
- Average True Range (ATR)
- RCUS 0.60
- UAN 3.15
- MACD
- RCUS 0.16
- UAN 0.42
- Stochastic Oscillator
- RCUS 74.19
- UAN 79.24
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.